Generic Facility Fee Unlikely To Be Charged Until A Few Months After GDUFA Implementation

FDA will need a bit of time to develop a comprehensive database of all the facilities that produce active pharmaceutical ingredients and finished dosage forms for the U.S. market as part of the proposed generic drug user fee program.